These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 24702879

  • 1. Efficacy of omalizumab in severe asthma with fungal sensitisation: a case report.
    Di Stefano F, Cinti B, Antonicelli L.
    Eur Ann Allergy Clin Immunol; 2014 Jan; 46(1):56-9. PubMed ID: 24702879
    [Abstract] [Full Text] [Related]

  • 2. Effect of omalizumab as add-on therapy on asthma-related quality of life in severe allergic asthma: a Brazilian study (QUALITX).
    Rubin AS, Souza-Machado A, Andradre-Lima M, Ferreira F, Honda A, Matozo TM, QUALITX Study Investigators.
    J Asthma; 2012 Apr; 49(3):288-93. PubMed ID: 22356355
    [Abstract] [Full Text] [Related]

  • 3. Omalizumab therapy in severe asthma: experience from the Spanish registry--some new approaches.
    Vennera Mdel C, Pérez De Llano L, Bardagí S, Ausin P, Sanjuas C, González H, Gullón JA, Martínez-Moragón E, Carretero JA, Vera E, Medina JF, Alvarez FJ, Entrenas LM, Padilla A, Irigaray R, Picado C, Spanish Registry.
    J Asthma; 2012 May; 49(4):416-22. PubMed ID: 22443408
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of omalizumab in a patient with severe asthma, low serum IgE level, and lack of sensitized allergens induced by oral steroid therapy: the usefulness of impulse oscillation for assessment of omalizumab therapy.
    Matsuno O, Komori C, Hang Y, Matsumoto T, Minamoto S.
    J Asthma; 2012 Oct; 49(8):839-42. PubMed ID: 22920591
    [Abstract] [Full Text] [Related]

  • 5. Comprehensive efficacy of omalizumab for severe refractory asthma: a time-series observational study.
    Tajiri T, Niimi A, Matsumoto H, Ito I, Oguma T, Otsuka K, Takeda T, Nakaji H, Inoue H, Iwata T, Nagasaki T, Kanemitsu Y, Izuhara Y, Mishima M.
    Ann Allergy Asthma Immunol; 2014 Oct; 113(4):470-5.e2. PubMed ID: 24994694
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma.
    Holgate ST, Chuchalin AG, Hébert J, Lötvall J, Persson GB, Chung KF, Bousquet J, Kerstjens HA, Fox H, Thirlwell J, Cioppa GD, Omalizumab 011 International Study Group.
    Clin Exp Allergy; 2004 Apr; 34(4):632-8. PubMed ID: 15080818
    [Abstract] [Full Text] [Related]

  • 7. Omalizumab in the treatment of asthma.
    Tan R, Corren J.
    Expert Rev Respir Med; 2011 Dec; 5(6):747-56. PubMed ID: 22082161
    [Abstract] [Full Text] [Related]

  • 8. Concomitant asthma medications in moderate-to-severe allergic asthma treated with omalizumab.
    Chen H, Eisner MD, Haselkorn T, Trzaskoma B.
    Respir Med; 2013 Jan; 107(1):60-7. PubMed ID: 23083840
    [Abstract] [Full Text] [Related]

  • 9. Impact of omalizumab on emergency-department visits, hospitalizations, and corticosteroid use among patients with uncontrolled asthma.
    Lafeuille MH, Dean J, Zhang J, Duh MS, Gorsh B, Lefebvre P.
    Ann Allergy Asthma Immunol; 2012 Jul; 109(1):59-64. PubMed ID: 22727159
    [Abstract] [Full Text] [Related]

  • 10. Itraconazole as 'bridge therapy' to anti-IgE in a patient with severe asthma with fungal sensitisation.
    Pizzimenti S, Bussolino C, Badiu I, Rolla G.
    BMJ Case Rep; 2013 Apr 17; 2013():. PubMed ID: 23598928
    [Abstract] [Full Text] [Related]

  • 11. Monitoring free serum IgE in severe asthma patients treated with omalizumab.
    Korn S, Haasler I, Fliedner F, Becher G, Strohner P, Staatz A, Taube C, Buhl R.
    Respir Med; 2012 Nov 17; 106(11):1494-500. PubMed ID: 22884459
    [Abstract] [Full Text] [Related]

  • 12. Omalizumab as add-on therapy to inhaled steroids for asthma.
    Hadj Tahar A.
    Issues Emerg Health Technol; 2004 Jun 17; (58):1-4. PubMed ID: 15455487
    [Abstract] [Full Text] [Related]

  • 13. Association between consistent omalizumab treatment and asthma control.
    Lafeuille MH, Gravel J, Zhang J, Gorsh B, Figliomeni M, Lefebvre P.
    J Allergy Clin Immunol Pract; 2013 Jan 17; 1(1):51-7. PubMed ID: 24229822
    [Abstract] [Full Text] [Related]

  • 14. [Pneumology. Anti-IgE antibodies in the treatment of asthma].
    Leuenberger P, Sauty A, Rochat T.
    Rev Med Suisse; 2007 Jan 10; 3(93):56-9. PubMed ID: 17354662
    [Abstract] [Full Text] [Related]

  • 15. A study into efficacy of omalizumab therapy in patients with severe persistent allergic asthma at a tertiary referral centre for asthma in Ireland.
    Subramaniam A, Al-Alawi M, Hamad S, O'Callaghan J, Lane SJ.
    QJM; 2013 Jul 10; 106(7):631-4. PubMed ID: 23550166
    [Abstract] [Full Text] [Related]

  • 16. Does anti-IgE therapy help in asthma? Efficacy and controversies.
    Avila PC.
    Annu Rev Med; 2007 Jul 10; 58():185-203. PubMed ID: 17059361
    [Abstract] [Full Text] [Related]

  • 17. Severe persistent asthma responsive to off-label use of omalizumab despite high and low levels of total serum IgE.
    Asai N, Ohkuni Y, Komatsu A, Matsunuma R, Nakashima K, Kaneko N.
    J Bras Pneumol; 2011 Jul 10; 37(4):567-70. PubMed ID: 21881749
    [No Abstract] [Full Text] [Related]

  • 18. Severe asthma with fungal sensitization.
    Agarwal R.
    Curr Allergy Asthma Rep; 2011 Oct 10; 11(5):403-13. PubMed ID: 21789577
    [Abstract] [Full Text] [Related]

  • 19. Omalizumab decreases exacerbations and allows a step down in daily inhaled corticosteroid dose in adults and children with moderate-to-severe asthma.
    Thomson NC.
    Evid Based Med; 2014 Aug 10; 19(4):135. PubMed ID: 24627175
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of omalizumab in asthmatic patients with IgE levels above 700 IU/mL: a retrospective study.
    Maselli DJ, Singh H, Diaz J, Peters JI.
    Ann Allergy Asthma Immunol; 2013 Jun 10; 110(6):457-61. PubMed ID: 23706716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.